Evaluation of the Safety Follow-up of Becaplermin or Placebo Gel Following Treatment of Chronic, Full Thickness Diabetic Ulcers

Clinical trial NCT00740922 · COMPLETED

Trial details

NCT number: NCT00740922
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status: COMPLETED
Study type: OBSERVATIONAL

Platelet-Derived Growth Factor Diabetic Foot Neoplasms

Start date: 1999-07-01
Enrollment: 563

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.